The phase 3 TETON-2 ( NCT05255991) clinical trial assessed inhaled treprostinil for idiopathic pulmonary fibrosis (IPF) and ...
As physician shortages and burnout threaten the patient experience in oncology, The US Oncology Network works to scale ...
The CDC’s Opioid Prescribing Guidelines initially stirred a significant amount of controversy among health care organizations ...
A panel featured during the NAACOS Spring 2026 Conference featured 3 experts discussing different methods of encouraging more ...
Payers and providers have long eyed each other with suspicion, but a growing cohort of health system leaders say that ...
Chris Johnson, MBA, founder and CEO of Bluebird Kids Health, identifies the emergence of "pediatric care deserts" as a ...
Bean announced 2 legislative responses: the PROMPT Act, which would send beneficiaries a monthly statement of Medicare claims ...
Bispecific antibodies are delivering unprecedented response rates in multiple myeloma, offering fast, flexible options ...
New reports spotlight inequities—from Black maternal mortality to 988’s youth impact—as well as rising cancer risk and gaps ...
Off-the-shelf cema-cel clears MRD at more than triple the rate of observation alone—and may propel a shift to frontline use ...
Formerly known as DB-OTO, lunsotogene parvec is an adeno-associated virus (AAV) vector–based gene therapy administered via a ...
Early evidence shows that the nationwide rollout of the 988 Suicide and Crisis Lifeline may be associated with a significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results